Brief: BerGenBio Q2 Operating Loss For Quarter Widens To NOK 64.7 Mln
Aug 18 (Reuters) - Bergenbio ASA BGBIO.OL :
* BERGENBIO ASA: RESULTS FOR THE SECOND QUARTER AND FIRST
HALF OF
2020
* REVENUE FOR Q2 AMOUNTED TO NOK 0.0 MILLION (NOK 0.0
MILLION)
* Q2 OPERATING LOSS FOR QUARTER CAME TO NOK 64.7 MILLION
(NOK 52.0
MILLION)
* TOTAL OPERATING EXPENSES FOR Q2 AMOUNTED TO NOK 64.7
MILLION
(NOK 52.0 MILLION)
Source text for Eikon: ID:nWkr7f77VY
Further company coverage: BGBIO.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Oncoinvent ASA
See all newsBrief: Oncoinvent To Raise Up To NOK 140 Million In Private Placement
Brief: Oncoinvent H1 Operating Loss NOK 69 Mln
Brief: Oncoinvent Secures New Patent Expanding Protection For Radspherin
Brief: Oncoinvent's Shares To Be Consolidated In Ratio Of 100:1
Brief: Oncoinvent To Increase Share Capital In Connection With Settlement Of Underwriting Fee